Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Rigontec GmbH
Woman and Man Max 99 years
Rigontec GmbH
Update Il y a 4 ans
A first in man study of RGT100 injection into solid tumors Primer estudio de inyección de RGT100 en sujetos con tumores sólidos
• Evaluate the safety and tolerability of intratumoral/intralesional injections of RGT100-PEI • Determine the recommended Phase 2 dose feasible for intratumoral/intralesional injections of RGT100-PEI ...
Country
None
organs
None
Specialty
None
unknown
More information